TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough results; Antag successfully completed financing.

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

An allergic reaction in babies can range from mild to life-threatening. Here’s how to tell if your child is having an ...

From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...

Ouch. You part your lips ever so slightly and you’re suddenly reminded of the painful sore in the corner of your mouth. The ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Established in 2022, the partnership is centred on the manufacturing of a cGMP 2000L drug substance commercially.

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

Many natural home remedies for dry scalp and help relieve dryness and itchiness at home. Here are some options worth trying.

New data reveals that longer-term lebrikizumab treatment significantly improves outcomes for patients with moderate-to-severe atopic dermatitis who didn’t meet response criteria by week 16.